Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Walter E. Washington Convention Center

Jun 15, 2025 7:00 AM - Jun 19, 2025 3:00 PM

801 Allen Y. Lew Place, NW, Washington, DC 20001-3614, USA

DIA 2025 Global Annual Meeting

Perspectives on the Adoption of Advanced Manufacturing Technologies

Session Chair(s)

Evdokia  Korakianiti, PharmD

Evdokia Korakianiti, PharmD

Head of Quality and Safety of Medicines, European Medicines Agency, Netherlands

Share regulatory efforts to support advanced manufacturing, including global regulatory developments from EMA and FDA; Listen to Industry cases studies showing implementation journeys and interactions with Regulators globally. Describe avenues available to industry and academia to support development of advanced manufacturing technologies; Discuss remaining challenges and priority areas for Industry and Regulators to work collaboratively to promote the adoption of advanced manufacturing technologies.

Learning Objective : Discuss regulatory efforts to support advanced manufacturing, including global regulatory developments from EMA and FDA; Describe avenues available to industry and academia to support development of advanced manufacturing technologies; Discuss priority areas for regulatory consideration to promote the adoption of advanced manufacturing technologies.

Speaker(s)

Benjamin  Stevens, PhD, MPH

Benjamin Stevens, PhD, MPH

Senior Director, Regulatory Affairs CMC Policy and Advocacy, Alnylam Pharmaceuticals, Inc., United States

Implementation Journey of a Digital Twin

Gert  Thurau, PhD

Gert Thurau, PhD

Head of CMC Regulatory Policy for Manufacturing Technology Innovation in , F. Hoffmann-La Roche Ltd, Switzerland

Implementation Journey for AI use in Manufacturing (without hallucinating)

Marcel  Hoefnagel, DRSc, PhD, MSc

Marcel Hoefnagel, DRSc, PhD, MSc

Senior Assessor Biopharmaceuticals, Medicines Evaluation Board , Netherlands

Enabling Regulatory Frameworks to Foster Innovation - Regulatory Perspective

Brian  Doyle

Brian Doyle

Senior Director, Technical Development, Moderna, United States

mRNA-Based Vaccines: From First Approvals Towards a Platform Technology

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.